BID (p15, Cleaved-Asn62) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-BID (p15, Cleaved-Asn62) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | BID (p15, Cleaved-Asn62) |
| Clone | polyclonal |
| Host Species | n/a |
| Reactive Species | human |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.1 mg |
| Concentration | n/a |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: BID (p15, Cleaved-Asn62) antibody detects endogenous levels of fragment of activated BID resulting from cleavage adjacent to Asn62. |
| Immunogen | Immunogen: The antiserum was produced against synthesized peptide derived from human BID. |
| Other Names | [apoptic death agonist; BH3 interacting domain death agonist; BH3-interacting domain death agonist; BH3-interacting domain death agonist p11; BH3-interacting domain death agonist p13; BH3-interacting domain death agonist p15; BID; BID isoform ES(1b); BID isoform L(2); BID isoform Si6; desmocollin type 4; FP497; Human BID coding sequence; MGC15319; MGC42355; p11 BID; p13 BID; p15 BID; p22 BID], [BID; BID; FP497; BID] |
| Gene, Accession # | [BID], Gene ID: 637, NCBI: NP_001187.1, UniProt: P55957 |
| Catalog # | MBS855666 |
| Price | $280 |
| Order / More Info | BID (p15, Cleaved-Asn62) Antibody from MYBIOSOURCE INC. |
| Product Specific References | Wang K., Genes Dev. 10:2859-2869(1996) [PubMed: 8918887]. Footz T.K., Genomics 51:472-475(1998) [PubMed: 9721221]. Renshaw S.A., J. Biol. Chem. 279:2846-2855(2004) [PubMed: 14583606]. Footz T.K., Genomics 51:472-475(1998) [PubMed: 9721221]. Renshaw S.A., J. Biol. Chem. 279:2846-2855(2004) [PubMed: 14583606]. |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies